CTC researchers and their collaborators have a
strong record of published research in prestigious international
journals. Recent journal articles are listed here.
Use the search link below to find specific articles, or
articles by year, author, trial or group, back to 2005.
Search for articles
Berlin JA, Morris S, Rockhold F, Askie L, Ghersi D, Waldstreicher J. Bumps and bridges on the road to responsible sharing of clinical trial data.
Clinical Trials 2014;
Bruhn MA, Townsend AR, Lee CK, Shivasami A, Price TJ, Wrin J, Arentz G, Tebbutt NC, Hocking C, Cunningham D, Hardingham JE. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
International Journal of Cancer 2014;
Burgess NG, Williams SJ, Hourigan LF, Brown GJ, Zanati SA, Singh R, Tam W, Butt J, Byth K, Bourke MJ. A management algorithm based on outcomes of clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions.
Clinical Gastroenterology and Hepatology 2014;
Carter HE, Zannino D, Simes RJ, Schofield DJ, Howard K, Zalcberg JR, Price TJ, Tebbutt NC. The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study.
European Journal of Cancer 2014;
Darlow BA, Marschner SL, Donoghoe M, Battin MR, Broadbent RS, Elder MJ, Hewson MP, Meyer MP, Ghadge A, Graham P, McNeill NJ, Kuschel CA, Tarnow-Mordi WO, Benefits Of Oxygen Saturation Targeting-New Zealand (BOOST-NZ) Collaborative Group. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes.
Journal of Pediatrics 2014;
Dietz HP, Mann KP. What is clinically relevant prolapse? An attempt at defining cutoffs for the clinical assessment of pelvic organ descent.
International Urogynecology Journal 2014;
Emery J, Doorey J, Jefford M, King M, Pirotta M, Hayne D, Martin A, Trevena L, Tim L, Constable R, Hawks C, Hyatt A, Hamid A, Violet J, Gill S, Frydenberg M, Schofield P. Protocol for the ProCare trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer.
BMJ Open 2014;
Funke-Kaiser A, Mann K, Colquhoun D, Zeller T, Hunt D, Simes J, Sullivan D, Sydow K, West M, White H, Blankenberg S, Tonkin AM, on behalf of the LIPID Study Investigators. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
International Journal of Cardiology 2014;
Greenhalf W, Ghaneh P, Neoptolemos JP, Palmer DH, Cox TF, Lamb RF, Garner E, Campbell F, Mackey JR, Costello E, Moore MJ, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Shannon J, Dervenis C, Glimelius B, Deakin M, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Halloran CM, Mayerle J, Oláh A, Jackson R, Rawcliffe CL, Scarpe A, Bassi C, Büchler MW, and for the European Study Group for Pancreatic Cancer. Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
Journal of the National Cancer Institute 2014;
Grimison PS, Stockler MR, Chatfield M, Thomson DB, Gebski V, Friedlander M, Boland AL, Houghton B, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong SS, Lewis CR, Vasey PA, Toner GC, Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Annals of Oncology 2014;
Hendrieckx C, Halliday JA, Bowden JP, Colman PG, Cohen N, Jenkins A, Speight J. Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics.
Diabetes Research and Clinical Practice 2014;
Hocking C, Hardingham J, Broadbridge V, Townsend AR, Tebbutt N, Cooper J, Ruszkiewicz A, Lee C, Price TJ. Can we accurately report PTEN status in advanced colorectal cancer?.
BMC Cancer 2014;
Horvath AR, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lorenz S, Monaghan PJ, Verhagen-Kamerbeek WD, Ebert C, Bossuyt PM, For the Test Evaluation Working Group of the European Federation of Clinical Chemistry Laboratory Medicine. From biomarkers to medical tests: the changing landscape of test evaluation.
Clinica Chimica Acta 2014;
Huober J, Cole BF, Rabaglio M, Giobbie-Hurder A, Wu J, Ejlertsen B., Bonnefoi H., Forbes JF, Neven P, Láng I, Smith I., Wardley A., Price KN, Goldhirsch A, Coates AS, Colleoni M, Gelber RD, Thürlimann B, for the BIG 1-98 Collaborative and International Breast Cancer Study Groups. Symptoms of endocrine treatment and outcome in the BIG 1-98 study.
Breast Cancer Research and Treatment 2014;
Jenkins AJ. Sometimes you have to give a man a fish.
Medical Journal of Australia 2014;
Jenkins AJ, Fu D, Azar M, Soner JA, Kaufman DG, Zhang S, Klein RL, Lopes-Virella MF, Ma JX, Lyons TJ. Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.
Journal of Diabetes and its Complications 2014;
Jonker DJ, Karapetis CS, Harbison C, O'Callaghan CJ, Tu D, Simes RJ, Malone DP, Langer C, Tebbutt N, Price TJ, Shapiro J, Siu LL, Wong RP, Bjarnason G, Moore MJ, Zalcberg JR, Khambata-Ford S. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.
British Journal of Cancer 2014;
Karapetis CS, Jonker D, Daneshmand M, Hanson JE, O'Callaghan CJ, Marginean EC, Zalcberg JR, Simes J, Moore MJ, Tebbutt N, Price TJ, Shapiro JD, Pavlakis N, Gibbs P, Hazel GV, Lee U, Haq R, Virk S, Tu D, Lorimer IA. PIK3CA, BRAF and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer—results from NCIC CTG/AGITG CO.17.
Clinical Cancer Research 2014;
Karikios DJ, Schofield D, Salkeld G, Mann KP, Trotman J, Stockler M. The rising cost of anticancer drugs in Australia.
Internal Medicine Journal 2014;
Laurie SA, Solomon BJ, Seymour L, Ellis PM, Goss GD, Shepherd FA, Boyer MJ, Arnold AM, Clingan P, Laberge F, Fenton D, Hirsh V, Zukin M, Stockler MR, Lee CW, Chen EX, Montenegro A, Ding K, Bradbury PA. Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.
European Journal of Cancer 2014;
McBride J, Jenkins A, Liu X, Zhang B, Lee K, Berry WL, Janknecht R, Griffin C, Aston CE, Lyons T, Tomasek JJ, Ma JX. Elevated circulation levels of an anti-angiogenic SERPIN in patients with diabetic microvascular complications impairs wound healing through suppression of Wnt signaling.
Journal of Investigative Dermatology 2014;
McCarthy N, Boyle F, Zdenkowski N, Bull J, Leong E, Simpson A, Kannourakis G, Francis PA, Chirgwin J, Abdi E, Gebski V, Veillard AS, Zannino D, Wilcken N, Reaby L, Lindsay DF, Badger HD, Forbes JF, Australia and New Zealand Breast Cancer Trials Group. Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).
Phu A, Xu Z, Brakoulias V, Mahant N, Fung VSC, Moore GD, Martin A, Starcevic V, Krause M. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.
Journal of Clinical Neuroscience 2014;
Ransom D, Wilson K, Fournier M, Simes RJ, Gebski V, Yip D, Tebbutt N, Karapetis CS, Ferry D, Gordon S, Price TJ. Final results of Australasian Gastro-Intestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
Annals of Oncology 2014;
Rodrigo N, Wong V, Shek KL, Martin A, Dietz HP. The use of 3-dimensional ultrasound of the pelvic floor to predict recurrence risk after pelvic reconstructive surgery.
Australian and New Zealand Journal of Obstetrics and Gynaecology 2014;
Schofield D, Cunich M, Shrestha R, Callander E, Passey M. E., Kelly S, Tanton R, Veerman L. The impact of diabetes on the labour force participation and income poverty of workers aged 45–64 years in Australia.
PloS One 2014;
Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Percival R, Kelly SJ. Indirect economic impacts of comorbidities on people with heart disease.
Circulation Journal 2014;
Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Percival R, Kelly SJ. How co-morbidities magnify the effect of arthritis on labour force participation and economic status: a costs of illness study in Australia.
Rheumatology International 2014;
Seimon RV, Espinoza D, Ivers L, Gebski V, Finer N, Legler UF, Sharma AM, James WP, Coutinho W, Caterson ID. Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease.
International Journal of Obesity 2014;
Sommeijer DW, Karapetis CS, Zalcberg JR, Tu D, Jonker DJ, Simes J, Tebbutt N, Yip D, Price TJ, O'Callaghan CJ. The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17.
Acta Oncologica 2014;
Tarnow-Mordi W, Soll RF. Probiotic supplementation in preterm infants: it is time to change practice.
Journal of Pediatrics 2014;
Tran B, Armstrong BK, Ebeling PR, English DR, Kimlin MG, van der Pols JC, Venn A, Gebski V, Whiteman DC, Webb PM, Neale RE. Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial.
American Journal of Clinical Nutrition 2014;
Viergever RF, Karam G, Reis A, Ghersi D. The quality of registration of clinical trials: still a problem.
PLoS One 2014;
White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S, for the LIPID study investigators. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID study.
Journal of the American College of Cardiology 2014;
Wong V, Shek KL, Goh J, Krause H, Martin A, Dietz HP. Cystocele recurrence after anterior colporrhaphy with and without mesh use.
European Journal of Obstetrics Gynecology and Reproductive Biology 2014;